REPLIGEN CORP - COMMON STOCK (RGEN)

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,095,854
Total 13F shares
57,114,183
Share change
+2,364,642
Total reported value
$9,078,983,361
Put/Call ratio
90%
Price per share
$159.01
Number of holders
435
Value change
+$388,815,346
Number of buys
208
Number of sells
215

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2023

As of 30 Sep 2023, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 435 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,114,183 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, Artisan Partners Limited Partnership, BROWN CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, and MACQUARIE GROUP LTD. This page lists 435 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.